Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Insight into molecular determinants of T3 vs. T4 recognition from mutations in thyroid hormone receptor alpha and beta.

Wejaphikul K, Groeneweg S, Hilhorst-Hofstee Y, Chatterjee VK, Peeters RP, Meima ME, Visser WE.

J Clin Endocrinol Metab. 2019 Feb 28. pii: jc.2018-02794. doi: 10.1210/jc.2018-02794. [Epub ahead of print]

PMID:
30817817
2.

Functional Analysis of Genetic Variation in the SECIS Element of Thyroid Hormone Activating Type 2 Deiodinase.

Zevenbergen C, Groeneweg S, Swagemakers SMA, de Jong A, Medici-Van den Herik E, Rispens M, Klootwijk W, Medici M, de Rijke YB, Meima ME, Larsen PR, Chavatte L, Venter D, Peeters RP, Van der Spek PJ, Visser WE.

J Clin Endocrinol Metab. 2019 May 1;104(5):1369-1377. doi: 10.1210/jc.2018-01605.

PMID:
30423129
3.

The current landscape of European registries for rare endocrine conditions.

Ali SR, Bryce J, Cools M, Korbonits M, Beun JG, Taruscio D, Danne T, Dattani M, Dekkers OM, Linglart A, Netchine I, Nordenstrom A, Patocs A, Persani L, Reisch N, Smyth A, Sumnik Z, Visser WE, Hiort O, Pereira AM, Ahmed SF.

Eur J Endocrinol. 2019 Jan 1;180(1):89-98. doi: 10.1530/EJE-18-0861.

4.

Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation.

Teumer A, Chaker L, Groeneweg S, Li Y, Di Munno C, Barbieri C, Schultheiss UT, Traglia M, Ahluwalia TS, Akiyama M, Appel EVR, Arking DE, Arnold A, Astrup A, Beekman M, Beilby JP, Bekaert S, Boerwinkle E, Brown SJ, De Buyzere M, Campbell PJ, Ceresini G, Cerqueira C, Cucca F, Deary IJ, Deelen J, Eckardt KU, Ekici AB, Eriksson JG, Ferrrucci L, Fiers T, Fiorillo E, Ford I, Fox CS, Fuchsberger C, Galesloot TE, Gieger C, Gögele M, De Grandi A, Grarup N, Greiser KH, Haljas K, Hansen T, Harris SE, van Heemst D, den Heijer M, Hicks AA, den Hollander W, Homuth G, Hui J, Ikram MA, Ittermann T, Jensen RA, Jing J, Jukema JW, Kajantie E, Kamatani Y, Kasbohm E, Kaufman JM, Kiemeney LA, Kloppenburg M, Kronenberg F, Kubo M, Lahti J, Lapauw B, Li S, Liewald DCM; Lifelines Cohort Study, Lim EM, Linneberg A, Marina M, Mascalzoni D, Matsuda K, Medenwald D, Meisinger C, Meulenbelt I, De Meyer T, Meyer Zu Schwabedissen HE, Mikolajczyk R, Moed M, Netea-Maier RT, Nolte IM, Okada Y, Pala M, Pattaro C, Pedersen O, Petersmann A, Porcu E, Postmus I, Pramstaller PP, Psaty BM, Ramos YFM, Rawal R, Redmond P, Richards JB, Rietzschel ER, Rivadeneira F, Roef G, Rotter JI, Sala CF, Schlessinger D, Selvin E, Slagboom PE, Soranzo N, Sørensen TIA, Spector TD, Starr JM, Stott DJ, Taes Y, Taliun D, Tanaka T, Thuesen B, Tiller D, Toniolo D, Uitterlinden AG, Visser WE, Walsh JP, Wilson SG, Wolffenbuttel BHR, Yang Q, Zheng HF, Cappola A, Peeters RP, Naitza S, Völzke H, Sanna S, Köttgen A, Visser TJ, Medici M.

Nat Commun. 2018 Oct 26;9(1):4455. doi: 10.1038/s41467-018-06356-1.

5.

Role of Leucine 341 in Thyroid Hormone Receptor Beta Revealed by a Novel Mutation Causing Thyroid Hormone Resistance.

Wejaphikul K, Groeneweg S, Dejkhamron P, Unachak K, Visser WE, Chatterjee VK, Visser TJ, Meima ME, Peeters RP.

Thyroid. 2018 Nov 27. doi: 10.1089/thy.2018.0146. [Epub ahead of print]

PMID:
30362879
6.

Pressure-volume analysis in athyroid patients off and on thyroxine supplementation: a pilot study.

B Bastos M, Massolt ET, Kam BLR, Peeters RP, Van Mieghem NM, Visser WE, den Uil CA.

Physiol Rep. 2018 Oct;6(20):e13883. doi: 10.14814/phy2.13883.

7.

Mutated Thyroid Hormone Transporter OATP1C1 Associates with Severe Brain Hypometabolism and Juvenile Neurodegeneration.

Strømme P, Groeneweg S, Lima de Souza EC, Zevenbergen C, Torgersbråten A, Holmgren A, Gurcan E, Meima ME, Peeters RP, Visser WE, Høneren Johansson L, Babovic A, Zetterberg H, Heuer H, Frengen E, Misceo D, Visser TJ.

Thyroid. 2018 Nov;28(11):1406-1415. doi: 10.1089/thy.2018.0595.

PMID:
30296914
8.

Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.

van Velsen EFS, Stegenga MT, van Kemenade FJ, Kam BLR, van Ginhoven TM, Visser WE, Peeters RP.

Thyroid. 2018 Aug;28(8):976-981. doi: 10.1089/thy.2018.0066. Epub 2018 Jul 30.

PMID:
29848239
9.

Serum microRNA profiles in athyroid patients on and off levothyroxine therapy.

Massolt ET, Chaker L, Visser TJ, Gillis AJM, Dorssers LCJ, Beukhof CM, Kam BLR, Franssen GJ, Brigante G, van Ginhoven TM, Visser WE, Looijenga LHJ, Peeters RP.

PLoS One. 2018 Apr 12;13(4):e0194259. doi: 10.1371/journal.pone.0194259. eCollection 2018.

10.

Effects of Chemical Chaperones on Thyroid Hormone Transport by MCT8 Mutants in Patient-Derived Fibroblasts.

Groeneweg S, van den Berge A, Meima ME, Peeters RP, Visser TJ, Visser WE.

Endocrinology. 2018 Mar 1;159(3):1290-1302. doi: 10.1210/en.2017-00846.

PMID:
29309566
11.

Effects of Thyroid Hormone on Urinary Concentrating Ability.

Massolt ET, Salih M, Beukhof CM, Kam BLR, Burger JW, Visser WE, Hoorn EJ, Peeters RP.

Eur Thyroid J. 2017 Sep;6(5):238-242. doi: 10.1159/000478521. Epub 2017 Jul 3.

12.

Thyroid State Regulates Gene Expression in Human Whole Blood.

Massolt ET, Meima ME, Swagemakers SMA, Leeuwenburgh S, van den Hout-van Vroonhoven MCGM, Brigante G, Kam BLR, van der Spek PJ, van IJcken WFJ, Visser TJ, Peeters RP, Visser WE.

J Clin Endocrinol Metab. 2018 Jan 1;103(1):169-178. doi: 10.1210/jc.2017-01144.

PMID:
29069456
13.

Outward-Open Model of Thyroid Hormone Transporter Monocarboxylate Transporter 8 Provides Novel Structural and Functional Insights.

Groeneweg S, Lima de Souza EC, Meima ME, Peeters RP, Visser WE, Visser TJ.

Endocrinology. 2017 Oct 1;158(10):3292-3306. doi: 10.1210/en.2017-00082.

PMID:
28977587
14.

Anemia in Patients With Resistance to Thyroid Hormone α: A Role for Thyroid Hormone Receptor α in Human Erythropoiesis.

van Gucht ALM, Meima ME, Moran C, Agostini M, Tylki-Szymanska A, Krajewska MW, Chrzanowska K, Efthymiadou A, Chrysis D, Demir K, Visser WE, Visser TJ, Chatterjee K, van Dijk TB, Peeters RP.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3517-3525. doi: 10.1210/jc.2017-00840.

15.

Disorder of thyroid hormone transport into the tissues.

Groeneweg S, Visser WE, Visser TJ.

Best Pract Res Clin Endocrinol Metab. 2017 Mar;31(2):241-253. doi: 10.1016/j.beem.2017.05.001. Epub 2017 May 24. Review.

PMID:
28648511
16.

Triiodothyroacetic acid in health and disease.

Groeneweg S, Peeters RP, Visser TJ, Visser WE.

J Endocrinol. 2017 Aug;234(2):R99-R121. doi: 10.1530/JOE-17-0113. Epub 2017 Jun 2. Review.

PMID:
28576869
17.

Sorafenib-Induced Changes in Thyroid Hormone Levels in Patients Treated for Hepatocellular Carcinoma.

Beukhof CM, van Doorn L, Visser TJ, Bins S, Visser WE, van Heerebeek R, van Kemenade FJ, de Rijke YB, de Herder WW, Chaker L, Mathijssen RH, Peeters RP.

J Clin Endocrinol Metab. 2017 Aug 1;102(8):2922-2929. doi: 10.1210/jc.2016-4025.

PMID:
28575418
18.

Resistance to Thyroid Hormone due to Heterozygous Mutations in Thyroid Hormone Receptor Alpha.

van Gucht ALM, Moran C, Meima ME, Visser WE, Chatterjee K, Visser TJ, Peeters RP.

Curr Top Dev Biol. 2017;125:337-355. doi: 10.1016/bs.ctdb.2017.02.001. Epub 2017 Mar 21. Review.

PMID:
28527577
19.

Therapeutic applications of thyroid hormone analogues in resistance to thyroid hormone (RTH) syndromes.

Groeneweg S, Peeters RP, Visser TJ, Visser WE.

Mol Cell Endocrinol. 2017 Dec 15;458:82-90. doi: 10.1016/j.mce.2017.02.029. Epub 2017 Feb 21. Review.

PMID:
28235578
20.

Clinical and Molecular Characteristics of SLC16A2 (MCT8) Mutations in Three Families with the Allan-Herndon-Dudley Syndrome.

Novara F, Groeneweg S, Freri E, Estienne M, Reho P, Matricardi S, Castellotti B, Visser WE, Zuffardi O, Visser TJ.

Hum Mutat. 2017 Mar;38(3):260-264. doi: 10.1002/humu.23140. Epub 2017 Jan 5.

PMID:
27805744
21.

Effects of thyroid hormone transporters MCT8 and MCT10 on nuclear activity of T3.

van Mullem AA, van Gucht ALM, Visser WE, Meima ME, Peeters RP, Visser TJ.

Mol Cell Endocrinol. 2016 Dec 5;437:252-260. doi: 10.1016/j.mce.2016.07.037. Epub 2016 Aug 1.

PMID:
27492966
22.

Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancer.

Massolt ET, van der Windt M, Korevaar TI, Kam BL, Burger JW, Franssen GJ, Lehmphul I, Köhrle J, Visser WE, Peeters RP.

Clin Endocrinol (Oxf). 2016 Nov;85(5):781-788. doi: 10.1111/cen.13101. Epub 2016 Jun 13.

PMID:
27175823
23.

Diverse Genotypes and Phenotypes of Three Novel Thyroid Hormone Receptor-α Mutations.

Demir K, van Gucht AL, Büyükinan M, Çatlı G, Ayhan Y, Baş VN, Dündar B, Özkan B, Meima ME, Visser WE, Peeters RP, Visser TJ.

J Clin Endocrinol Metab. 2016 Aug;101(8):2945-54. doi: 10.1210/jc.2016-1404. Epub 2016 May 4.

PMID:
27144938
24.

Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease.

Massolt ET, Effraimidis G, Korevaar TI, Wiersinga WM, Visser WE, Peeters RP, Drexhage HA.

PLoS One. 2016 Apr 19;11(4):e0153892. doi: 10.1371/journal.pone.0153892. eCollection 2016.

25.

Selenium Status Is Positively Associated with Bone Mineral Density in Healthy Aging European Men.

Beukhof CM, Medici M, van den Beld AW, Hollenbach B, Hoeg A, Visser WE, de Herder WW, Visser TJ, Schomburg L, Peeters RP.

PLoS One. 2016 Apr 7;11(4):e0152748. doi: 10.1371/journal.pone.0152748. eCollection 2016.

26.

Triiodothyroacetic Acid Treatment in MCT8 Deficiency: A Word of Nuance.

Visser WE, Heuer H, Visser TJ.

Thyroid. 2016 May;26(5):615-7. doi: 10.1089/thy.2016.0191. No abstract available.

PMID:
27042766
27.

Tissue-Specific Suppression of Thyroid Hormone Signaling in Various Mouse Models of Aging.

Visser WE, Bombardieri CR, Zevenbergen C, Barnhoorn S, Ottaviani A, van der Pluijm I, Brandt R, Kaptein E, van Heerebeek R, van Toor H, Garinis GA, Peeters RP, Medici M, van Ham W, Vermeij WP, de Waard MC, de Krijger RR, Boelen A, Kwakkel J, Kopchick JJ, List EO, Melis JP, Darras VM, Dollé ME, van der Horst GT, Hoeijmakers JH, Visser TJ.

PLoS One. 2016 Mar 8;11(3):e0149941. doi: 10.1371/journal.pone.0149941. eCollection 2016.

28.

Resistance to Thyroid Hormone Alpha in an 18-Month-Old Girl: Clinical, Therapeutic, and Molecular Characteristics.

van Gucht AL, Meima ME, Zwaveling-Soonawala N, Visser WE, Fliers E, Wennink JM, Henny C, Visser TJ, Peeters RP, van Trotsenburg AS.

Thyroid. 2016 Mar;26(3):338-46. doi: 10.1089/thy.2015.0463. Epub 2016 Feb 16.

PMID:
26782358
29.

Association of antiepileptic drug usage, trace elements and thyroid hormone status.

Zevenbergen C, Korevaar TI, Schuette A, Peeters RP, Medici M, Visser TJ, Schomburg L, Visser WE.

Eur J Endocrinol. 2016 Apr;174(4):425-32. doi: 10.1530/EJE-15-1081. Epub 2015 Dec 23.

PMID:
26701870
30.

Transport of Iodothyronines by Human L-Type Amino Acid Transporters.

Zevenbergen C, Meima ME, Lima de Souza EC, Peeters RP, Kinne A, Krause G, Visser WE, Visser TJ.

Endocrinology. 2015 Nov;156(11):4345-55. doi: 10.1210/en.2015-1140. Epub 2015 Aug 25.

PMID:
26305885
31.

Normal Thyroid Function and the Risk of Atrial Fibrillation: the Rotterdam Study.

Chaker L, Heeringa J, Dehghan A, Medici M, Visser WE, Baumgartner C, Hofman A, Rodondi N, Peeters RP, Franco OH.

J Clin Endocrinol Metab. 2015 Oct;100(10):3718-24. doi: 10.1210/jc.2015-2480. Epub 2015 Aug 11.

PMID:
26262438
32.

Placental Angiogenic Factors Are Associated With Maternal Thyroid Function and Modify hCG-Mediated FT4 Stimulation.

Korevaar TI, Steegers EA, de Rijke YB, Visser WE, Jaddoe VW, Visser TJ, Medici M, Peeters RP.

J Clin Endocrinol Metab. 2015 Oct;100(10):E1328-34. doi: 10.1210/jc.2015-2553. Epub 2015 Jul 23.

PMID:
26204137
33.

Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study.

Korevaar TI, Steegers EA, de Rijke YB, Schalekamp-Timmermans S, Visser WE, Hofman A, Jaddoe VW, Tiemeier H, Visser TJ, Medici M, Peeters RP.

Eur J Epidemiol. 2015 Sep;30(9):1057-66. doi: 10.1007/s10654-015-0039-0. Epub 2015 May 12.

34.

Thyroid function in pregnancy: what is normal?

Medici M, Korevaar TI, Visser WE, Visser TJ, Peeters RP.

Clin Chem. 2015 May;61(5):704-13. doi: 10.1373/clinchem.2014.236646. Epub 2015 Mar 31. Review.

35.

Genetic determination of the hypothalamic-pituitary-thyroid axis: where do we stand?

Medici M, Visser WE, Visser TJ, Peeters RP.

Endocr Rev. 2015 Apr;36(2):214-44. doi: 10.1210/er.2014-1081. Epub 2015 Mar 9. Review.

PMID:
25751422
36.

In vitro and mouse studies support therapeutic utility of triiodothyroacetic acid in MCT8 deficiency.

Kersseboom S, Horn S, Visser WE, Chen J, Friesema EC, Vaurs-Barrière C, Peeters RP, Heuer H, Visser TJ.

Mol Endocrinol. 2015 Jan 7:me00009999. [Epub ahead of print]

PMID:
25565257
37.

In vitro and mouse studies supporting therapeutic utility of triiodothyroacetic acid in MCT8 deficiency.

Kersseboom S, Horn S, Visser WE, Chen J, Friesema EC, Vaurs-Barrière C, Peeters RP, Heuer H, Visser TJ.

Mol Endocrinol. 2014 Dec;28(12):1961-70. doi: 10.1210/me.2014-1135.

38.

Subclinical thyroid dysfunction and the risk of stroke: a systematic review and meta-analysis.

Chaker L, Baumgartner C, Ikram MA, Dehghan A, Medici M, Visser WE, Hofman A, Rodondi N, Peeters RP, Franco OH.

Eur J Epidemiol. 2014 Nov;29(11):791-800. doi: 10.1007/s10654-014-9946-8. Epub 2014 Sep 2. Review.

PMID:
25179793
39.

Maternal early-pregnancy thyroid function is associated with subsequent hypertensive disorders of pregnancy: the generation R study.

Medici M, Korevaar TI, Schalekamp-Timmermans S, Gaillard R, de Rijke YB, Visser WE, Visser W, de Muinck Keizer-Schrama SM, Hofman A, Hooijkaas H, Bongers-Schokking JJ, Tiemeier H, Jaddoe VW, Visser TJ, Peeters RP, Steegers EA.

J Clin Endocrinol Metab. 2014 Dec;99(12):E2591-8. doi: 10.1210/jc.2014-1505.

PMID:
25157540
40.

Functional analysis of novel genetic variation in the thyroid hormone activating type 2 deiodinase.

Zevenbergen C, Klootwijk W, Peeters RP, Medici M, de Rijke YB, Huisman SA, Goeman H, Boot E, de Kuijper G, de Waal KH, Meima ME, Larsen PR, Visser TJ, Visser WE.

J Clin Endocrinol Metab. 2014 Nov;99(11):E2429-36. doi: 10.1210/jc.2014-2281. Epub 2014 Aug 20.

PMID:
25140401
41.

Resistance to thyroid hormone caused by a mutation in thyroid hormone receptor (TR)α1 and TRα2: clinical, biochemical, and genetic analyses of three related patients.

Moran C, Agostini M, Visser WE, Schoenmakers E, Schoenmakers N, Offiah AC, Poole K, Rajanayagam O, Lyons G, Halsall D, Gurnell M, Chrysis D, Efthymiadou A, Buchanan C, Aylwin S, Chatterjee KK.

Lancet Diabetes Endocrinol. 2014 Aug;2(8):619-26. doi: 10.1016/S2213-8587(14)70111-1. Epub 2014 Jun 23. Erratum in: Lancet Diabetes Endocrinol. 2014 Aug;2(8):e14.

42.

Soluble Flt1 and placental growth factor are novel determinants of newborn thyroid (dys)function: the generation R study.

Korevaar TI, Steegers EA, Schalekamp-Timmermans S, Ligthart S, de Rijke YB, Visser WE, Visser W, de Muinck Keizer-Schrama SM, Hofman A, Hooijkaas H, Bongers-Schokking JJ, Russcher H, Tiemeier H, Jaddoe VW, Visser TJ, Medici M, Peeters RP.

J Clin Endocrinol Metab. 2014 Sep;99(9):E1627-34. doi: 10.1210/jc.2014-1884. Epub 2014 Jun 2.

PMID:
24885632
43.

Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease.

Medici M, Porcu E, Pistis G, Teumer A, Brown SJ, Jensen RA, Rawal R, Roef GL, Plantinga TS, Vermeulen SH, Lahti J, Simmonds MJ, Husemoen LL, Freathy RM, Shields BM, Pietzner D, Nagy R, Broer L, Chaker L, Korevaar TI, Plia MG, Sala C, Völker U, Richards JB, Sweep FC, Gieger C, Corre T, Kajantie E, Thuesen B, Taes YE, Visser WE, Hattersley AT, Kratzsch J, Hamilton A, Li W, Homuth G, Lobina M, Mariotti S, Soranzo N, Cocca M, Nauck M, Spielhagen C, Ross A, Arnold A, van de Bunt M, Liyanarachchi S, Heier M, Grabe HJ, Masciullo C, Galesloot TE, Lim EM, Reischl E, Leedman PJ, Lai S, Delitala A, Bremner AP, Philips DI, Beilby JP, Mulas A, Vocale M, Abecasis G, Forsen T, James A, Widen E, Hui J, Prokisch H, Rietzschel EE, Palotie A, Feddema P, Fletcher SJ, Schramm K, Rotter JI, Kluttig A, Radke D, Traglia M, Surdulescu GL, He H, Franklyn JA, Tiller D, Vaidya B, de Meyer T, Jørgensen T, Eriksson JG, O'Leary PC, Wichmann E, Hermus AR, Psaty BM, Ittermann T, Hofman A, Bosi E, Schlessinger D, Wallaschofski H, Pirastu N, Aulchenko YS, de la Chapelle A, Netea-Maier RT, Gough SC, Meyer Zu Schwabedissen H, Frayling TM, Kaufman JM, Linneberg A, Räikkönen K, Smit JW, Kiemeney LA, Rivadeneira F, Uitterlinden AG, Walsh JP, Meisinger C, den Heijer M, Visser TJ, Spector TD, Wilson SG, Völzke H, Cappola A, Toniolo D, Sanna S, Naitza S, Peeters RP.

PLoS Genet. 2014 Feb 27;10(2):e1004123. doi: 10.1371/journal.pgen.1004123. eCollection 2014 Feb.

44.

Thyroid function within the normal range and the risk of depression: a population-based cohort study.

Medici M, Direk N, Visser WE, Korevaar TI, Hofman A, Visser TJ, Tiemeier H, Peeters RP.

J Clin Endocrinol Metab. 2014 Apr;99(4):1213-9. doi: 10.1210/jc.2013-3589. Epub 2014 Feb 24.

PMID:
24564323
45.

The role of Arg445 and Asp498 in the human thyroid hormone transporter MCT8.

Groeneweg S, Friesema EC, Kersseboom S, Klootwijk W, Visser WE, Peeters RP, Visser TJ.

Endocrinology. 2014 Feb;155(2):618-26. doi: 10.1210/en.2013-1521. Epub 2013 Nov 21.

PMID:
24265446
46.

Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study.

Korevaar TI, Schalekamp-Timmermans S, de Rijke YB, Visser WE, Visser W, de Muinck Keizer-Schrama SM, Hofman A, Ross HA, Hooijkaas H, Tiemeier H, Bongers-Schokking JJ, Jaddoe VW, Visser TJ, Steegers EA, Medici M, Peeters RP.

J Clin Endocrinol Metab. 2013 Nov;98(11):4382-90. doi: 10.1210/jc.2013-2855. Epub 2013 Sep 13.

PMID:
24037884
47.

Women with high early pregnancy urinary iodine levels have an increased risk of hyperthyroid newborns: the population-based Generation R Study.

Medici M, Ghassabian A, Visser W, de Muinck Keizer-Schrama SM, Jaddoe VW, Visser WE, Hooijkaas H, Hofman A, Steegers EA, Bongers-Schokking JJ, Ross HA, Tiemeier H, Visser TJ, de Rijke YB, Peeters RP.

Clin Endocrinol (Oxf). 2014 Apr;80(4):598-606. doi: 10.1111/cen.12321. Epub 2013 Oct 9.

PMID:
23992400
48.

Ethnic differences in maternal thyroid parameters during pregnancy: the Generation R study.

Korevaar TI, Medici M, de Rijke YB, Visser W, de Muinck Keizer-Schrama SM, Jaddoe VW, Hofman A, Ross HA, Visser WE, Hooijkaas H, Steegers EA, Tiemeier H, Bongers-Schokking JJ, Visser TJ, Peeters RP.

J Clin Endocrinol Metab. 2013 Sep;98(9):3678-86. doi: 10.1210/jc.2013-2005. Epub 2013 Jul 8.

PMID:
23836936
49.

Different causes of reduced sensitivity to thyroid hormone: diagnosis and clinical management.

Visser WE, van Mullem AA, Visser TJ, Peeters RP.

Clin Endocrinol (Oxf). 2013 Nov;79(5):595-605. doi: 10.1111/cen.12281. Epub 2013 Aug 17. Review.

PMID:
23834164
50.

Thyroid disorders in older adults.

Visser WE, Visser TJ, Peeters RP.

Endocrinol Metab Clin North Am. 2013 Jun;42(2):287-303. doi: 10.1016/j.ecl.2013.02.008. Epub 2013 Mar 29. Review.

PMID:
23702402

Supplemental Content

Loading ...
Support Center